
Role of 18 F-fluorodeoxyglucose Positron Emission Tomography scan in differentiating enhancing brain tumors
Author(s) -
Kajal Das,
Bhagwant Rai Mittal,
R. K. Vasistha,
Paramjit Singh,
S. N. Mathuriya
Publication year - 2011
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/0972-3919.106698
Subject(s) - medicine , positron emission tomography , lymphoma , nuclear medicine , fluorodeoxyglucose , standardized uptake value , magnetic resonance imaging , glioma , pathology , radiology , cancer research
To determine whether F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG PET) can be used to differentiate among common enhancing brain tumors such as gliomas, metastatic brain tumors, and lymphoma.